Skip to main content
Log in

Pseudohypoparathyroidism: a missed window of treatment opportunity?

  • Neuro-Images
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Saleem S, Aslam HM, Anwar M, Anwar S, Saleem M, Saleem A, Rehmanie MA (2013) Fahr’s syndrome: literature review of current evidence. Orphanet J Rare Dis 8:156

    Article  Google Scholar 

  2. Westenberger A, Klein C (2014) The genetics of primary familial brain calcifications. Curr Neurol Neurosci Rep 14:490

    Article  Google Scholar 

  3. Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G et al (2018) Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol 14:476–500

    Article  CAS  Google Scholar 

  4. Mantovani G (2011) Clinical review: pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 96:3020–3030

    Article  CAS  Google Scholar 

  5. Song CY, Zhao ZX, Li W, Sun CC, Liu YM (2017) Pseudohypoparathyroidism with basal ganglia calcification: a case report of rare cause of reversible Parkinsonism. Medicine 96:e6312

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. David.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

David, K., Stinkens, K. & Decallonne, B. Pseudohypoparathyroidism: a missed window of treatment opportunity?. Acta Neurol Belg 121, 259–260 (2021). https://doi.org/10.1007/s13760-019-01268-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01268-3

Navigation